Lung cancer: where we are?

Lung cancer is the first cause of death for tumors worldwide. However several improvements have been obtained mainly due to the increased biologic knowledge. In fact today with the term lung cancer we consider a group of several diseases, distinguished according to histology and molecular features. These aspects are fundamental in order to define the most active therapeutic strategies. This landscape is rapidly evolving and every year new data are available. So far it is particularly important to have the possibility to discuss the new data together with outstanding experts in order to improve the knowledge for a better cure for patients.

RESPONSABILI SCIENTIFICI:

Dr. Angelo Delmonte, Dr. Nicola Normanno, Dr.ssa Elisabetta Parisi, Dr. Lucio Crinò

CREDITI ECM:

Tale evento è accreditato e la partecipazione darà diritto all'acquisizione di 7 ECM per Medico Chirurgo. Obiettivo formativo nr. 3Tale evento è accreditato e la partecipazione darà diritto all'acquisizione di 3 ECM per Biologo,  Infermiere. Obiettivo formativo nr. 3

ISCRIZIONE:

1. Download the “PROEVENTI” app on your smartphone.
2. Login or create a new account.
3. Enter the event pin: LYMPHOMAS26.
4. You are now on the event page, click on “REGISTRATION” at the top.

RESPONSABILI SCIENTIFICI: Dr. Gerardo MusuracaDr. Nicola Normanno

Gratuito previo iscrizione.